Virtual Medicinal Product (VMP)
-
Zalcitabine 375microgram tablets
Name Details
Current Name
Zalcitabine 375microgram tablets
|
Start Date
13-05-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J05AF03
BNF |
Current BNF
05030100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
05030100
|
Start Date
24-02-2005
|
End Date
09-10-2006
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41796111000001100 |
12-05-2023 |
|
324819009 |
13-05-2003 |
11-05-2023 |
VMP Ingredients
VMP ingredients table
Zalcitabine |
Based on Ingredient Substance |
|
375 microgram |
|
Name
Zalcitabine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
375
Strength and UOM (Dmr)
Parent Products
-
VTM
Zalcitabine
-
VMP
(Current) Zalcitabine 375microgram tablets
Virtual Medicinal Product Pack (VMPP) Information